Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Luteal contraception.

S Yen1, G Garzo, J Liu

  • 1Department of Reproductive Medicine, School of Medicine, University of California, San Diego, La Jolla 92093.

Contraception
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assisted hatching reduces the age-related decline in IVF outcome in women younger than age 43 without increasing miscarriage or monozygotic twinning.

Journal of assisted reproduction and genetics·1998
Same author

17-hydroxyprogesterone levels are not helpful in the prediction of HCG timing in in vitro fertilization cycles.

Journal of assisted reproduction and genetics·1996
Same author

Cornual pregnancies in patients with prior salpingectomy undergoing in vitro fertilization and embryo transfer.

Fertility and sterility·1996
Same author

Fatigue reduction by sequential stimulation of multiple motor points in a muscle.

Clinical orthopaedics and related research·1995
Same author

Prospective, auto-controlled study on reinsemination of failed-fertilized oocytes by intracytoplasmic sperm injection.

Fertility and sterility·1995
Same author

Fluidity of the lipid domain of cell wall from Mycobacterium chelonae.

Proceedings of the National Academy of Sciences of the United States of America·1995
Same journal

Crisis Pregnancy Center Names in the United States, 2024.

Contraception·2026
Same journal

Findings from the Choices about Abortion CaRE Options (CARE) Study: A Discrete-Choice Experiment.

Contraception·2026
Same journal

Comparative effectiveness of 200mcg versus 400mcg misoprostol dosing for medication abortion from 24-27 weeks' gestation.

Contraception·2026
Same journal

Reasons patients decide to replace or extend their long-acting reversible contraceptive before the full duration of pregnancy prevention: a qualitative study.

Contraception·2026
Same journal

Awareness of abortion medications by mail options among abortion patients at 6 clinics: Findings from a pilot study.

Contraception·2026
Same journal

A phase 1, randomized, open-label, single-dose relative bioavailability study of upper arm injection of depot medroxyprogesterone acetate comparing pharmacokinetics and hormone indicators of ovulation with anterior thigh and abdomen injection.

Contraception·2026
See all related articles

RU 486 disrupts the hypothalamic-gonadotropin-corpus luteum-endometrial axis, causing uterine bleeding and altering hormone secretion. This study offers insights for developing new contraceptive methods.

Area of Science:

  • Reproductive Endocrinology
  • Pharmacology

Background:

  • The hypothalamic-gonadotropin-corpus luteum-endometrial (H-P-CL-E) axis regulates the menstrual cycle.
  • RU 486 is known for its antiprogesterone effects on the endometrium.

Purpose of the Study:

  • To investigate the impact of oral RU 486 on the H-P-CL-E axis during the mid-luteal and late-luteal phases.
  • To assess RU 486's effects with and without human chorionic gonadotropin (hCG)-induced pseudopregnancy.

Main Methods:

  • Longitudinal study design with daily RU 486 dosing over three consecutive cycles (control, treatment, recovery).
  • Frequent blood sampling to monitor hormone levels (LH, estradiol, progesterone) and luteinizing hormone (LH) pulsatility.
  • Endometrial biopsy and assessment of response to gonadotropin-releasing hormone (GnRH) stimulation.
Keywords:
BiologyContraceptionContraception ResearchCorpus Luteum HormonesDrugs--administraction and dosageEndocrine SystemEstradiol--analysisEstrogensEvaluationFamily PlanningFemale ContraceptionFollicle Stimulating Hormone--analysisGonadotropinsGonadotropins, PituitaryHormonesLuteinizing Hormone--analysisMenstrual CycleMenstruationPhysiologyProgestational HormonesProgesterone--analysisReproductionReproductive Control AgentsTreatment

Related Experiment Videos

Main Results:

  • During the mid-luteal phase, RU 486 induced uterine bleeding, decreased LH pulse amplitude, and impaired GnRH response, followed by rebound LH secretion and prolonged corpus luteum function.
  • During the late-luteal phase, RU 486 induced uterine bleeding, decreased LH pulsatility, and accelerated hormone decline, even with hCG rescue.
  • RU 486 demonstrated antiprogesterone effects on the endometrium and significant impacts on the H-P-CL-E axis.

Conclusions:

  • RU 486 significantly affects the H-P-CL-E axis beyond its endometrial actions.
  • The drug's impact on hormonal regulation and corpus luteum function provides a basis for novel contraceptive strategies.
  • Findings suggest potential for once-monthly contraceptive methods based on RU 486's hormonal effects.